한글목차

세계 절제 기술 시장 규모는 2024년 61억 1,000만 달러에서 예측 기간 동안 9.5%의 CAGR로 2029년에는 96억 2,000만 달러 규모로 성장할 것으로 예상됩니다.

기술별로는 고주파 절제 부문이 2023년 가장 큰 점유율을 차지했습니다."

심근 절제술과 종양 절제술에 대한 수요 증가, 조기 진단에 대한 인식 증가, 기술 발전이 이 부문의 가장 큰 점유율을 차지하고 있습니다.

"제품별로는 소모품 부문이 2023년 가장 큰 점유율을 차지했습니다."

소모품 부문의 큰 점유율은 최종사용자 시설에서 절제 시스템의 채택이 증가함에 따라 뒷받침되고 있습니다. 소모품은 환자의 안전을 보장하기 위해 매 시술마다 교체해야 합니다. 미용 및 통증 관리와 같은 용도의 확대, 최근 기술 발전, 환자 안전을 보장하기 위한 엄격한 규제 정책 등이 이 부문의 높은 점유율에 기여하고 있습니다.

"용도별로는 심혈관 질환 치료 부문이 2023년 가장 큰 점유율을 차지했습니다."

CVD에 대한 절제 치료의 성공률 향상과 새로운 절제 기술이 이 부문의 성장을 주도하고 있습니다.

"아시아태평양이 예측 기간 동안 가장 높은 성장세를 보일 것으로 예상됩니다."

특히 신흥국의 의료 서비스 및 인프라에 대한 지속적인 투자 증가가 절제술 시스템 도입 증가를 뒷받침하고 있습니다. 주요 업체들은 절제술에 대한 수요 증가에 대응하기 위해 신흥국에서의 입지 확대에 주력하고 있습니다. 또한, 이 지역의 병원 수가 증가함에 따라 고급 치료 시술의 가용성과 접근성이 향상되어 절제 시스템 및 소모품에 대한 수요가 더욱 증가하고 있습니다.

세계 절제 기술 시장을 조사했으며, 시장 개요, 시장 성장에 영향을 미치는 각종 영향요인 분석, 기술·특허 동향, 법규 및 상환 환경, 사례 연구, 시장 규모 추정 및 예측, 각종 부문별·지역별·주요 국가별 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 소개

제2장 조사 방법

제3장 주요 요약

제4장 주요 인사이트

제5장 시장 개요

• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회
  • 과제
• 밸류체인 분석
• 공급망 분석
• 생태계 분석
• 규제 상황
• 상환 시나리오 분석
• 투자와 자금 조달 시나리오
• 가격 분석
• 무역 분석
• 특허 분석
• Porter's Five Forces 분석
• 주요 이해관계자와 구입 기준
• 주요 회의와 이벤트
• 사례 연구 분석
• 기술 분석
• 고객 비즈니스에 영향을 미치는 동향/디스럽션
• 미충족 수요
• AI/생성형 AI가 절제 기술 시장에 미치는 영향

제6장 절제 기술 시장 : 기술별

• 고주파 절제
• 레이저/광 절제
• 초음파 절제
• 전기 절제
• 냉동 절제
• 마이크로파 절제
• 펄스 필드 절제
• 하이드로 서멀/하이드로 메커니컬 절제

제7장 절제 기술 시장 : 제품별

• 고주파 절제 시스템
  • 온도 제어 고주파 절제 시스템
  • 유체 냉각식 고주파 절제 시스템
  • 로봇 카테터 조작 시스템
• 레이저/광 절제 시스템
  • 엑시머 레이저 절제 시스템
  • 콜드 레이저 절제 시스템
• 초음파 절제 시스템
  • 초음파 외과용 절제 시스템
  • 고강도 초점식 초음파 절제 시스템
  • 체외 충격파 결석 파쇄 시스템
  • 자기 공명 유도 집속 초음파 절제 시스템
• 전기 절제 시스템
  • 아르곤 플라즈마/빔 응고 시스템
  • 비가역적 전기 천공 절제 시스템
• 냉동 절제 시스템
  • 표피 및 피하 동결 융해 디바이스
• 마이크로파 절제 시스템
  • 마이크로파 온열 요법 시스템
• 하이드로 서멀/하이드로 메커니컬 절제 시스템
  • 자궁내막 하이드로 서멀 풍선 절제 기기
• 소모품

제8장 절제 기술 시장 : 용도별

• 심혈관질환 치료
• 암 치료
  • 간암
  • 신장암
  • 전립선암
  • 폐암
  • 골전이
  • 유방암
• 정형외과 치료
• 미용성형
• 비뇨기과 치료
• 부인과 치료
• 통증 관리
• 안과 치료
• 기타

제9장 절제 기술 시장 : 최종사용자별

• 병원·외과 센터·절제 센터
• 외래 수술 센터
• 메디컬 스파 및 미용·피부과 클리닉
• 기타

제10장 절제 기술 시장 : 지역별

• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동 및 아프리카

제11장 경쟁 상황

• 주요 기업의 전략/유력 기업
• 매출 분석
• 시장 점유율 분석
• 기업 평가 매트릭스 : 주요 기업
• 기업 평가 매트릭스 : 스타트업/중소기업
• 기업 가치 평가와 재무 지표
• 브랜드/제품 비교
• 경쟁 시나리오

제12장 기업 개요

• 주요 기업
  • JOHNSON & JOHNSON
  • MEDTRONIC
  • BOSTON SCIENTIFIC CORPORATION
  • ABBOTT
  • ATRICURE, INC.
  • ANGIODYNAMICS
  • CONMED CORPORATION
  • OLYMPUS CORPORATION
  • VARIAN MEDICAL SYSTEMS, INC.
  • SMITH+NEPHEW
  • STRYKER
  • CYNOSURE LUTRONIC
  • BIOVENTUS
  • MERIT MEDICAL SYSTEMS
  • CANYON MEDICAL INC.
• 기타 기업
  • ARTHREX, INC.
  • ICECURE MEDICAL
  • MINIMAX MEDICAL HOLDING GROUP
  • CARDIOFOCUS
  • EDAP TMS
  • MERMAID MEDICAL
  • MONTERIS
  • SONABLATE CORP.
  • ECO MEDICAL
  • SURGNOVA

제13장 부록

영문목차

The global ablation technology market is projected to reach USD 9.62 billion by 2029 from USD 6.11 billion in 2024, at a CAGR of 9.5% from 2024 to 2029. Increasing risk for targeted diseases, supportive regulatory standards, and strategic partnerships and collaborations have driven demand for ablation technology market.

"The radiofrequency ablation segment of technology segment held the largest share of the market in 2023"

The ablation technology market is segmented based on technology into radiofrequency ablation, laser/light ablation, ultrasound ablation, electrical ablation, cryoablation, microwave ablation, pulsed field ablation and hydrothermal/hydromechanical ablation. Increasing demand for cardiac and tumor ablation procedures, growing awareness for early diagnosis, and technological advancements contributes to the largest share for this segment.

"The consumable segment of product segment held the largest share of the market in 2023"

The ablation technology market is segmented based on product into systems and consumables. Large share of consumables segment is supported by rising adoption of ablation systems in the end user facilities. Consumables need to be replaced for each procedure ensuring the patient safety. Extended application areas such as aesthetics, pain management, recent technological advancements, and strict regulatory policies to ensuring patient safety contribute to the highest share of the segment.

"The cardiovascular disease treatment segment for application segment held the largest share of the market in 2023".

Based on application, the ablation technology market is segmented by application into cardiovascular disease treatment, cancer treatment, orthopedic treatment, cosmetic/aesthetic treatment, urological treatment, gynecological treatment, pain management, ophthalmological treatment and other applications. Cardiovascular disease treatment segment held largest share of the segment in 2023. Improved success rate of ablation treatment for CVD and emerging technologies in ablation drives the segment growth.

"The Ambulatory surgery centers segment for the end user segment is projected to register a significant CAGR during the forecast period."

The ablation technology market is segmented by end user into hospitals, surgical centers and ablation centers, ambulatory surgery centers, medical spas and aesthetic clinics & dermatology clinics, and other end users. The hospitals, surgical centers and ablation centers segment accounted for a significant market share in 2023. Improved insurance coverage and an increase in outpatient treatments are two major factors driving the expansion of the ambulatory surgery center segment.

"The market in the Asia pacific region is expected to witness the highest growth during the forecast period."

Consistent rise in investment for healthcare services and infrastructure, especially in emerging economies, supports the rising installation of ablation systems. Key players in the market are focusing on expanding their presence in emerging countries to cater the increasing demand for ablation procedures. Moreover, the increasing number of hospitals, particularly in APAC region, increases the availability and accessibility of advanced treatment procedures, further driving the demand for ablation systems and consumables.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1-30%, Tier 2-42%, and Tier 3- 28%
• By Designation: Director-level-10%, C-level-14%, and Others-76%
• By Region: North America-40%, Europe-30%, Asia Pacific-22%, Latin America-6%, and the Middle East & Africa-2%

The prominent players in the ablation technology market Johnson & Johnson (US), Medtronic (US), Boston Scientific Corporation (US), Abbott (US), Atricure, Inc. (US), AngioDynamics (US), CONMED corporation (US), Olympus (Japan) among others.

Research Coverage

This report studies the ablation technology market based on technology, product, application, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions.

Reasons to Buy the Report

The report will help the market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall ablation technology market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.

This report provides insights on the following pointers:

• Analysis of key drivers (Emerging technologies in the field of ablation, increasing demand for minimally invasive procedures, favorable reimbursement scenario in developed markets, and growing target patient population), restraints (presence of strong alternative therapies, stringent regulatory system), opportunities (growth potential in emerging countries), and challenges (focus on reuse and reprocessing of devices, therapeutic challenges and hazardous effects of ablation) influencing the growth of the ablation technology market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the ablation technology market
• Market Development: Comprehensive information about lucrative markets-the report analyses the ablation technology market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the ablation technology market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players - such as Johnson & Johnson (US), Medtronic (US), Boston Scientific Corporation (US), Abbott (US), Atricure, Inc. (US), AngioDynamics (US), CONMED corporation (US), Olympus (Japan) among others.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 INCLUSIONS AND EXCLUSIONS
• 1.4 STUDY SCOPE
  • 1.4.1 SEGMENTS CONSIDERED
  • 1.4.2 YEARS CONSIDERED
  • 1.4.3 CURRENCY CONSIDERED
• 1.5 STAKEHOLDERS
• 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key secondary sources
    • 2.1.1.2 Objectives of secondary research
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key primary sources
    • 2.1.2.2 Objectives of primary research
    • 2.1.2.3 Key primary insights
    • 2.1.2.4 Breakdown of primaries
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 BOTTOM-UP APPROACH
    • 2.2.1.1 Company revenue estimation approach
    • 2.2.1.2 Customer-based market estimation
    • 2.2.1.3 Growth forecast
    • 2.2.1.4 CAGR projections
• 2.3 DATA TRIANGULATION
• 2.4 RESEARCH LIMITATIONS
• 2.5 MARKET SHARE ANALYSIS
• 2.6 STUDY ASSUMPTIONS
• 2.7 GROWTH RATE ASSUMPTIONS
• 2.8 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 ABLATION TECHNOLOGY MARKET OVERVIEW
• 4.2 NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2024 VS. 2029 (USD MILLION)
• 4.3 ASIA PACIFIC: ABLATION TECHNOLOGY MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
• 4.4 EUROPE: ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
• 4.5 GEOGRAPHIC SNAPSHOT OF ABLATION TECHNOLOGY MARKET

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Emerging ablation technologies
    • 5.2.1.2 Increasing demand for minimally invasive procedures
    • 5.2.1.3 Growing target patient population
      • 5.2.1.3.1 Rapid growth in geriatric population with higher risk of targeted diseases
      • 5.2.1.3.2 Increasing incidence of cancer and sports injuries
      • 5.2.1.3.3 Rising prevalence of atrial fibrillation and other cardiovascular diseases
    • 5.2.1.4 Favorable reimbursement scenario in developed markets
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Strong market positioning of alternative therapies
    • 5.2.2.2 Stringent regulatory systems
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Growth potential in emerging economies
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Focus on reuse and reprocessing of devices
    • 5.2.4.2 Therapeutic challenges and hazardous effects of ablation
• 5.3 VALUE CHAIN ANALYSIS
  • 5.3.1 RESEARCH & PRODUCT DEVELOPMENT
  • 5.3.2 RAW MATERIAL PROCUREMENT AND MANUFACTURING
  • 5.3.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
• 5.4 SUPPLY CHAIN ANALYSIS
  • 5.4.1 MANUFACTURERS
    • 5.4.1.1 Prominent companies
    • 5.4.1.2 Small and medium-sized enterprises
  • 5.4.2 END USERS
• 5.5 ECOSYSTEM ANALYSIS
• 5.6 REGULATORY LANDSCAPE
  • 5.6.1 REGULATORY ANALYSIS
    • 5.6.1.1 North America
      • 5.6.1.1.1 US
      • 5.6.1.1.2 Canada
    • 5.6.1.2 Europe
    • 5.6.1.3 Asia Pacific
      • 5.6.1.3.1 Japan
      • 5.6.1.3.2 China
      • 5.6.1.3.3 India
    • 5.6.1.4 Latin America
      • 5.6.1.4.1 Brazil
  • 5.6.2 REGULATORY APPROVALS
  • 5.6.3 KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.6.3.1 North America
    • 5.6.3.2 Europe
    • 5.6.3.3 Asia Pacific
    • 5.6.3.4 Latin America
    • 5.6.3.5 Middle East & Africa
• 5.7 REIMBURSEMENT SCENARIO ANALYSIS
• 5.8 INVESTMENT AND FUNDING SCENARIO
• 5.9 PRICING ANALYSIS
• 5.10 TRADE ANALYSIS
  • 5.10.1 IMPORT DATA FOR ABLATION PRODUCTS (HS CODE 9018)
  • 5.10.2 EXPORT DATA FOR ABLATION PRODUCTS (HS CODE 9018)
• 5.11 PATENT ANALYSIS
  • 5.11.1 TOP PATENT OWNERS/APPLICANTS
  • 5.11.2 LIST OF MAJOR PATENTS
• 5.12 PORTER'S FIVE FORCES ANALYSIS
  • 5.12.1 THREAT OF NEW ENTRANTS
  • 5.12.2 THREAT OF SUBSTITUTES
  • 5.12.3 BARGAINING POWER OF SUPPLIERS
  • 5.12.4 BARGAINING POWER OF BUYERS
  • 5.12.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.13.2 KEY BUYING CRITERIA
• 5.14 KEY CONFERENCES AND EVENTS, 2024-2025
• 5.15 CASE STUDY ANALYSIS
  • 5.15.1 RADIOFREQUENCY ABLATION ANALYSIS CASE STUDY
  • 5.15.2 THERMOCOOL CATHETER CASE STUDY
• 5.16 TECHNOLOGY ANALYSIS
  • 5.16.1 KEY TECHNOLOGIES
    • 5.16.1.1 Thermal ablation technology
    • 5.16.1.2 Non-thermal ablation technology
  • 5.16.2 COMPLEMENTARY TECHNOLOGIES
    • 5.16.2.1 Medical cooling systems
  • 5.16.3 ADJACENT TECHNOLOGIES
    • 5.16.3.1 Ablation planning software
• 5.17 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
• 5.18 UNMET NEEDS
• 5.19 IMPACT OF AI/GEN AI ON ABLATION TECHNOLOGY MARKET
  • 5.19.1 KEY USE CASES

6 ABLATION TECHNOLOGY MARKET, BY TECHNOLOGY

• 6.1 INTRODUCTION
• 6.2 RADIOFREQUENCY ABLATION
  • 6.2.1 LOWER COST AND HIGHER EFFICACY TO PROPEL MARKET GROWTH
• 6.3 LASER/LIGHT ABLATION
  • 6.3.1 LOWER RISK OF TISSUE DAMAGE AND BETTER REAL-TIME MONITORING TO AID MARKET GROWTH
• 6.4 ULTRASOUND ABLATION
  • 6.4.1 HIGH INCIDENCE OF LIVER TUMORS AND CANCER TO FUEL MARKET GROWTH
• 6.5 ELECTRICAL ABLATION
  • 6.5.1 INCREASING NUMBER OF CARDIAC ARRESTS TO BOOST ADOPTION
• 6.6 CRYOABLATION
  • 6.6.1 FEWER COMPLICATIONS AND SHORTER PROCEDURAL TIME TO DRIVE MARKET
• 6.7 MICROWAVE ABLATION
  • 6.7.1 FASTER ABLATION TIME AND LESSER PROCEDURAL PAIN TO AUGMENT MARKET GROWTH
• 6.8 PULSED-FIELD ABLATION
  • 6.8.1 IMPROVED SAFETY, SHORTER PROCEDURAL TIME, AND FEWER COMPLICATIONS TO PROPEL MARKET GROWTH
• 6.9 HYDROTHERMAL/HYDROMECHANICAL ABLATION
  • 6.9.1 INCREASED USAGE IN GYNECOLOGICAL DISORDERS AND MENORRHAGIA TO AID MARKET GROWTH

7 ABLATION TECHNOLOGY MARKET, BY PRODUCT

• 7.1 INTRODUCTION
• 7.2 RADIOFREQUENCY ABLATION SYSTEMS
  • 7.2.1 TEMPERATURE-CONTROLLED RADIOFREQUENCY ABLATION SYSTEMS
    • 7.2.1.1 Technological advancements and improved clinical outcomes to propel segment growth
  • 7.2.2 FLUID-COOLED RADIOFREQUENCY ABLATION SYSTEMS
    • 7.2.2.1 Rising incidence of arrhythmia and growing focus on reducing collateral tissue damage to boost demand
  • 7.2.3 ROBOTIC CATHETER MANIPULATION SYSTEMS
    • 7.2.3.1 Manual control of catheter movement and remote navigation to fuel segment
• 7.3 LASER/LIGHT ABLATION SYSTEMS
  • 7.3.1 EXCIMER LASER ABLATION SYSTEMS
    • 7.3.1.1 Low direct tissue interaction, precise ablation zone, and high procedural efficiency to drive adoption
  • 7.3.2 COLD LASER ABLATION SYSTEMS
    • 7.3.2.1 Cold laser ablator treatment to release endorphins and support pain management
• 7.4 ULTRASOUND ABLATION SYSTEMS
  • 7.4.1 ULTRASONIC SURGICAL ABLATION SYSTEMS
    • 7.4.1.1 Development of user-friendly surgical ablation systems to drive segment growth
  • 7.4.2 HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION SYSTEMS
    • 7.4.2.1 Low procedural time and reduced bleeding to support system adoption
  • 7.4.3 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY SYSTEMS
    • 7.4.3.1 Growing incidence of obesity and diabetes to drive segment
  • 7.4.4 MAGNETIC RESONANCE-GUIDED FOCUSED ULTRASOUND ABLATION SYSTEMS
    • 7.4.4.1 Non-pregnancy safe treatment procedure to limit adoption
• 7.5 ELECTRICAL ABLATION SYSTEMS
  • 7.5.1 ARGON PLASMA/BEAM COAGULATION SYSTEMS
    • 7.5.1.1 Increased focus on treating Barrett's esophagus without dysplasia to augment segment growth
  • 7.5.2 IRREVERSIBLE ELECTROPORATION ABLATION SYSTEMS
    • 7.5.2.1 Selective targeting and better control to aid segment growth
• 7.6 CRYOABLATION SYSTEMS
  • 7.6.1 TECHNOLOGICAL ADVANCEMENTS AND INTRODUCTION OF NEW CRYOPROBES TO AID ADOPTION
  • 7.6.2 EPIDERMAL AND SUBCUTANEOUS CRYOABLATION DEVICES
• 7.7 MICROWAVE ABLATION SYSTEMS
  • 7.7.1 PRODUCTION OF LARGE ABLATION ZONES WITHOUT HEAT-SINK EFFECT ON SURROUNDING TISSUES TO DRIVE MARKET
  • 7.7.2 MICROWAVE THERMOTHERAPY SYSTEMS
• 7.8 HYDROTHERMAL/HYDROMECHANICAL ABLATION SYSTEMS
  • 7.8.1 INCREASED NEED FOR MINIMALLY INVASIVE PROCEDURES FOR GYNECOLOGICAL DISORDERS TO SUPPORT MARKET GROWTH
  • 7.8.2 ENDOMETRIAL HYDROTHERMAL BALLOON ABLATION DEVICES
• 7.9 CONSUMABLES
  • 7.9.1 GROWING PREFERENCE FOR ADVANCED MINIMALLY INVASIVE PROCEDURES TO SPUR MARKET GROWTH

8 ABLATION TECHNOLOGY MARKET, BY APPLICATION

• 8.1 INTRODUCTION
• 8.2 CARDIOVASCULAR DISEASE TREATMENT
  • 8.2.1 INCREASING TARGET PATIENT POPULATION TO PROPEL MARKET GROWTH
• 8.3 CANCER TREATMENT
  • 8.3.1 HIGH PREVALENCE OF CANCER AND NEED FOR ADVANCED TREATMENT PROCEDURES TO AUGMENT MARKET GROWTH
  • 8.3.2 LIVER CANCER
  • 8.3.3 KIDNEY CANCER
  • 8.3.4 PROSTATE CANCER
  • 8.3.5 LUNG CANCER
  • 8.3.6 BONE METASTASIS
  • 8.3.7 BREAST CANCER
• 8.4 ORTHOPEDIC TREATMENT
  • 8.4.1 GROWING DISEASE PREVALENCE AND RISING GERIATRIC POPULATION TO SPUR MARKET GROWTH
• 8.5 COSMETIC/AESTHETIC SURGERY
  • 8.5.1 INCREASING DEMAND FOR AESTHETIC SURGICAL PROCEDURES TO FUEL MARKET GROWTH
• 8.6 UROLOGICAL TREATMENT
  • 8.6.1 HIGH DEMAND FOR MINIMALLY INVASIVE PROCEDURES AMONG PATIENTS TO DRIVE MARKET
• 8.7 GYNECOLOGICAL TREATMENT
  • 8.7.1 INCREASING REPRODUCTIVE HEALTH CONCERNS AND DECREASING FERTILITY RATE TO PROPEL MARKET GROWTH
• 8.8 PAIN MANAGEMENT
  • 8.8.1 MINIMUM RECOVERY TIME AND LONG-LASTING PAIN RELIEF TO SUPPORT MARKET GROWTH
• 8.9 OPHTHALMOLOGICAL TREATMENT
  • 8.9.1 RISING PREVALENCE OF VISION DISORDERS AMONG ALL AGE GROUPS TO AID MARKET GROWTH
• 8.10 OTHER APPLICATIONS

9 ABLATION TECHNOLOGY MARKET, BY END USER

• 9.1 INTRODUCTION
• 9.2 HOSPITALS, SURGICAL CENTERS, AND ABLATION CENTERS
  • 9.2.1 HIGH ADOPTION OF ROBOTIC PROCEDURES IN SURGERIES AND IMPROVED HEALTHCARE INFRASTRUCTURE TO DRIVE MARKET
• 9.3 AMBULATORY SURGERY CENTERS
  • 9.3.1 NEED FOR COST-EFFECTIVE OUTPATIENT TREATMENTS TO SPUR MARKET GROWTH
• 9.4 MEDICAL SPAS AND AESTHETIC & DERMATOLOGY CLINICS
  • 9.4.1 INCREASING PREFERENCE FOR MINIMALLY INVASIVE AND NON-INVASIVE AESTHETIC PROCEDURES TO BOOST MARKET GROWTH
• 9.5 OTHER END USERS

10 ABLATION TECHNOLOGY MARKET, BY REGION

• 10.1 INTRODUCTION
• 10.2 NORTH AMERICA
  • 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 10.2.2 US
    • 10.2.2.1 US to dominate North American ablation technology market during forecast period
  • 10.2.3 CANADA
    • 10.2.3.1 Rising burden of cancer and growing demand for minimally invasive procedures to support market growth
• 10.3 EUROPE
  • 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 10.3.2 GERMANY
    • 10.3.2.1 Developed healthcare infrastructure and high incidence of chronic diseases to support market growth
  • 10.3.3 FRANCE
    • 10.3.3.1 Growing geriatric population and rising prevalence of cancer to aid market growth
  • 10.3.4 UK
    • 10.3.4.1 Rising target patient population and growing awareness about advanced treatment options to drive market
  • 10.3.5 ITALY
    • 10.3.5.1 Increasing number of clinical trials and growing focus on advanced research activities to augment market growth
  • 10.3.6 SPAIN
    • 10.3.6.1 Increasing government research funding and growing focus on effective cancer diagnosis to propel market growth
  • 10.3.7 REST OF EUROPE
• 10.4 ASIA PACIFIC
  • 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 10.4.2 JAPAN
    • 10.4.2.1 Presence of universal healthcare reimbursement system to augment market growth
  • 10.4.3 CHINA
    • 10.4.3.1 Increased patient pool and favorable government initiatives to fuel market growth
  • 10.4.4 INDIA
    • 10.4.4.1 Modernization of healthcare infrastructure and increased medical tourism to aid market growth
  • 10.4.5 AUSTRALIA
    • 10.4.5.1 Increased research investments and favorable government initiatives to spur market growth
  • 10.4.6 SOUTH KOREA
    • 10.4.6.1 Focus on healthcare R&D and supportive government initiatives to positively impact market growth
  • 10.4.7 REST OF ASIA PACIFIC
• 10.5 LATIN AMERICA
  • 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 10.5.2 BRAZIL
    • 10.5.2.1 Increasing government funding and growing burden of chronic diseases to propel market growth
  • 10.5.3 MEXICO
    • 10.5.3.1 Availability of advanced care initiatives and awareness programs to fuel market growth
  • 10.5.4 REST OF LATIN AMERICA
• 10.6 MIDDLE EAST & AFRICA
  • 10.6.1 IMPROVED HEALTHCARE INFRASTRUCTURE AND HIGH PUBLIC-PRIVATE INVESTMENTS TO STIMULATE MARKET GROWTH
  • 10.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

• 11.1 INTRODUCTION
• 11.2 KEY PLAYER STRATEGY/RIGHT TO WIN
  • 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN ABLATION TECHNOLOGY MARKET
• 11.3 REVENUE ANALYSIS, 2019-2023
• 11.4 MARKET SHARE ANALYSIS, 2023
• 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 11.5.1 STARS
  • 11.5.2 EMERGING LEADERS
  • 11.5.3 PERVASIVE PLAYERS
  • 11.5.4 PARTICIPANTS
  • 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 11.5.5.1 Company footprint
    • 11.5.5.2 Technology footprint
    • 11.5.5.3 Product footprint
    • 11.5.5.4 Application footprint
    • 11.5.5.5 End-user footprint
    • 11.5.5.6 Region footprint
• 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 11.6.1 PROGRESSIVE COMPANIES
  • 11.6.2 RESPONSIVE COMPANIES
  • 11.6.3 DYNAMIC COMPANIES
  • 11.6.4 STARTING BLOCKS
  • 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
• 11.7 COMPANY VALUATION AND FINANCIAL METRICS
  • 11.7.1 FINANCIAL METRICS
  • 11.7.2 COMPANY VALUATION
• 11.8 BRAND/PRODUCT COMPARISON
• 11.9 COMPETITIVE SCENARIO
  • 11.9.1 PRODUCT LAUNCHES AND APPROVALS
  • 11.9.2 DEALS
  • 11.9.3 EXPANSIONS

12 COMPANY PROFILES

• 12.1 KEY PLAYERS
  • 12.1.1 JOHNSON & JOHNSON
    • 12.1.1.1 Business overview
    • 12.1.1.2 Products offered
    • 12.1.1.3 Recent developments
      • 12.1.1.3.1 Product approvals
      • 12.1.1.3.2 Deals
    • 12.1.1.4 MnM view
      • 12.1.1.4.1 Key strengths
      • 12.1.1.4.2 Strategic choices
      • 12.1.1.4.3 Weaknesses and competitive threats
  • 12.1.2 MEDTRONIC
    • 12.1.2.1 Business overview
    • 12.1.2.2 Products offered
    • 12.1.2.3 Recent developments
      • 12.1.2.3.1 Product approvals
    • 12.1.2.4 MnM view
      • 12.1.2.4.1 Key strengths
      • 12.1.2.4.2 Strategic choices
      • 12.1.2.4.3 Weaknesses and competitive threats
  • 12.1.3 BOSTON SCIENTIFIC CORPORATION
    • 12.1.3.1 Business overview
    • 12.1.3.2 Products offered
    • 12.1.3.3 Recent developments
      • 12.1.3.3.1 Product approvals
      • 12.1.3.3.2 Deals
    • 12.1.3.4 MnM view
      • 12.1.3.4.1 Key strengths
      • 12.1.3.4.2 Strategic choices made
      • 12.1.3.4.3 Weaknesses and competitive threats
  • 12.1.4 ABBOTT
    • 12.1.4.1 Business overview
    • 12.1.4.2 Products offered
    • 12.1.4.3 Recent developments
      • 12.1.4.3.1 Product approvals
      • 12.1.4.3.2 Deals
  • 12.1.5 ATRICURE, INC.
    • 12.1.5.1 Business overview
    • 12.1.5.2 Products offered
    • 12.1.5.3 Recent developments
      • 12.1.5.3.1 Product launches and approvals
  • 12.1.6 ANGIODYNAMICS
    • 12.1.6.1 Business overview
    • 12.1.6.2 Products offered
    • 12.1.6.3 Recent developments
      • 12.1.6.3.1 Deals
  • 12.1.7 CONMED CORPORATION
    • 12.1.7.1 Business overview
    • 12.1.7.2 Products offered
  • 12.1.8 OLYMPUS CORPORATION
    • 12.1.8.1 Products offered
    • 12.1.8.2 Recent developments
      • 12.1.8.2.1 Product launches
      • 12.1.8.2.2 Deals
  • 12.1.9 VARIAN MEDICAL SYSTEMS, INC.
    • 12.1.9.1 Business overview
    • 12.1.9.2 Products offered
    • 12.1.9.3 Recent developments
      • 12.1.9.3.1 Product launches
      • 12.1.9.3.2 Deals
  • 12.1.10 SMITH+NEPHEW
    • 12.1.10.1 Business overview
    • 12.1.10.2 Product offered
    • 12.1.10.3 Recent developments
      • 12.1.10.3.1 Expansions
  • 12.1.11 STRYKER
    • 12.1.11.1 Business overview
    • 12.1.11.2 Products offered
    • 12.1.11.3 Recent developments
      • 12.1.11.3.1 Product approvals
      • 12.1.11.3.2 Expansions
  • 12.1.12 CYNOSURE LUTRONIC
    • 12.1.12.1 Business overview
    • 12.1.12.2 Products offered
    • 12.1.12.3 Recent developments
      • 12.1.12.3.1 Deals
  • 12.1.13 BIOVENTUS
    • 12.1.13.1 Business overview
    • 12.1.13.2 Products offered
      • 12.1.13.2.1 Deals
  • 12.1.14 MERIT MEDICAL SYSTEMS
    • 12.1.14.1 Business overview
    • 12.1.14.2 Products offered
  • 12.1.15 CANYON MEDICAL INC.
    • 12.1.15.1 Business overview
    • 12.1.15.2 Products offered
• 12.2 OTHER PLAYERS
  • 12.2.1 ARTHREX, INC.
  • 12.2.2 ICECURE MEDICAL
  • 12.2.3 MINIMAX MEDICAL HOLDING GROUP
  • 12.2.4 CARDIOFOCUS
  • 12.2.5 EDAP TMS
  • 12.2.6 MERMAID MEDICAL
  • 12.2.7 MONTERIS
  • 12.2.8 SONABLATE CORP.
  • 12.2.9 ECO MEDICAL
  • 12.2.10 SURGNOVA

13 APPENDIX

• 13.1 DISCUSSION GUIDE
• 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 13.3 CUSTOMIZATION OPTIONS
• 13.4 RELATED REPORTS
• 13.5 AUTHOR DETAILS